MICA: An experimental medicine model for fast acting antidepressant drug treatment in treatment resistant depression
MICA:快速作用抗抑郁药物治疗难治性抑郁症的实验医学模型
基本信息
- 批准号:MR/S035591/1
- 负责人:
- 金额:$ 101.03万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2019
- 资助国家:英国
- 起止时间:2019 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Depression is common and disabling. There are effective treatments for depression but around 30% of patients are not helped by existing treatments. Recent evidence suggests that these patients respond well to a new class of medication acting on the brain's glutamate system. For example, a low dose of the anaesthetic agent ketamine, which acts on the glutamate system, led to improvements in depression very quickly which lasted for up to a week. Ketamine itself is not an ideal treatment for depression since it is also a drug of abuse and has many side effects. There is therefore a huge need to develop similar drugs to ketamine, which work well in this subgroup of patients but without these unwanted effects. Potential new drugs exist but it is very time consuming and expensive to test all these drugs, at different doses, in full clinical trials. Experimental medicine models can help as they allow these drugs to be tested in smaller groups in the lab, exploring effects on key mechanisms of illness rather than less sensitive clinical ratings of mood. This is thought to provide more accurate information and help select the most promising treatments to take forward to full clinical trial testing. Data from rodent models suggests that drugs like ketamine may have distinct effects on the brain and behaviour. These involve effects on how rewarding information is handled and how emotional memories are retrieved and experienced. However, these mechanisms have not been tested in humans. We therefore plan to test the effects of ketamine on reward learning and emotional memory retrieval in humans. We will first characterise these effects in healthy people as this will allow us to identify core processes affected by ketamine and ascertain whether these actions are dose specific. We will then validate these mechanisms in depressed patients who have not responded to conventional treatments. We will assess learning about reward and punishment and the recall of established memories as well as the brain networks which underpin these effects. We think that ketamine will have effects on a network in the brain involving the lateral habenula, medial prefrontal cortex and hippocampus, which have been implicated in the ketamine studies using animals and which play a key role in learning, memory and emotion. These two studies will help develop a set of measures which can be used in future studies to select the most promising drug treatments for treatment resistant depression.
抑郁症很常见,而且会导致残疾。抑郁症有有效的治疗方法,但大约30%的患者没有得到现有治疗的帮助。最近的证据表明,这些患者对一类作用于大脑谷氨酸系统的新型药物反应良好。例如,低剂量的麻醉剂氯胺酮,作用于谷氨酸系统,导致抑郁症的改善非常迅速,持续长达一周。氯胺酮本身并不是抑郁症的理想治疗方法,因为它也是一种滥用药物,并且有许多副作用。因此,非常需要开发与氯胺酮类似的药物,这些药物在这一亚组患者中效果良好,但没有这些不良反应。潜在的新药是存在的,但在全面的临床试验中以不同的剂量测试所有这些药物是非常耗时和昂贵的。实验医学模型可以提供帮助,因为它们允许这些药物在实验室中以较小的群体进行测试,探索对疾病关键机制的影响,而不是对情绪的不太敏感的临床评级。这被认为提供了更准确的信息,并有助于选择最有希望的治疗方法进行全面的临床试验测试。来自啮齿动物模型的数据表明,氯胺酮等药物可能对大脑和行为有明显的影响。这些影响涉及如何处理奖励信息以及如何检索和体验情感记忆。然而,这些机制尚未在人类中进行过测试。因此,我们计划测试氯胺酮对人类奖励学习和情感记忆提取的影响。我们将首先在健康人群中验证这些影响,因为这将使我们能够确定氯胺酮影响的核心过程,并确定这些作用是否具有剂量特异性。然后,我们将在对常规治疗无反应的抑郁症患者中验证这些机制。我们将评估关于奖励和惩罚的学习,以及对已建立记忆的回忆,以及支持这些效应的大脑网络。我们认为氯胺酮会对大脑中涉及外侧缰核、内侧前额叶皮层和海马体的网络产生影响,这些网络在使用动物的氯胺酮研究中有牵连,并在学习、记忆和情绪中发挥关键作用。这两项研究将有助于制定一套措施,可用于未来的研究,以选择最有前途的药物治疗难治性抑郁症。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings.
- DOI:10.1038/s41380-021-01183-1
- 发表时间:2022-01
- 期刊:
- 影响因子:11
- 作者:Pulcu E;Guinea C;Cowen PJ;Murphy SE;Harmer CJ
- 通讯作者:Harmer CJ
Dynamic modulation of inequality aversion in human interpersonal negotiations.
- DOI:10.1038/s42003-022-03318-8
- 发表时间:2022-04-14
- 期刊:
- 影响因子:5.9
- 作者:Murphy, Daniel A. J.;Xie, Jiaxin;Harmer, Catherine J.;Browning, Michael;Pulcu, Erdem
- 通讯作者:Pulcu, Erdem
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Harmer其他文献
Antidepressant Effects on Reward Processing: Can We Predict Response?
- DOI:
10.1016/j.biopsych.2020.02.152 - 发表时间:
2020-05-01 - 期刊:
- 影响因子:
- 作者:
Catherine Harmer - 通讯作者:
Catherine Harmer
136. Neural Response to Implicit Emotions as Biomarkers of Clinical Response to SSRI Treatment in Depression
- DOI:
10.1016/j.biopsych.2017.02.148 - 发表时间:
2017-05-15 - 期刊:
- 影响因子:
- 作者:
Beata Godlewska;Michael Browning;Ray Norbury;Artemis Igoumenou;Philip Cowen;Catherine Harmer - 通讯作者:
Catherine Harmer
873. Dissociable Temporal Effects of Bupropion on Behavioural Measures of Emotional and Reward Processing in Major Depressive Disorder
- DOI:
10.1016/j.biopsych.2017.02.598 - 发表时间:
2017-05-15 - 期刊:
- 影响因子:
- 作者:
Annabel Walsh;Michael Browning;Wayne Drevets;Maura Furey;Catherine Harmer - 通讯作者:
Catherine Harmer
118. Perspectives of Teenage Girls on Conversations With Primary Care Providers (PCPs) About Weight, Eating, and Exercise
- DOI:
10.1016/j.jadohealth.2019.11.121 - 发表时间:
2020-02-01 - 期刊:
- 影响因子:
- 作者:
Catherine Harmer;Kristen Larsen;Constance Baldwin;Taylor Starr - 通讯作者:
Taylor Starr
207. A Double-Blind Randomised Study Investigating Ketamine Sustained Effect on Stress Response
一项双盲随机研究:探究氯胺酮对应激反应的持续作用
- DOI:
10.1016/j.biopsych.2025.02.444 - 发表时间:
2025-05-01 - 期刊:
- 影响因子:9.000
- 作者:
Sara Costi;Pilar Artiach Hortelano;Erdem Pulcu;Rupert McShane;Philip Cowen;Catherine Harmer;Susannah Murphy - 通讯作者:
Susannah Murphy
Catherine Harmer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Harmer', 18)}}的其他基金
MICA: 5-HT4 receptor activation as a novel mechanism of antidepressant action
MICA:5-HT4 受体激活作为抗抑郁作用的新机制
- 批准号:
MR/P012604/1 - 财政年份:2017
- 资助金额:
$ 101.03万 - 项目类别:
Research Grant
D-cycloserine augmented single-session CBT for panic disorder
D-环丝氨酸增强单次 CBT 治疗恐慌症
- 批准号:
MR/J011878/1 - 财政年份:2012
- 资助金额:
$ 101.03万 - 项目类别:
Research Grant
Cognitive biomarkers of antidepressant drug efficacy
抗抑郁药物疗效的认知生物标志物
- 批准号:
G0801432/1 - 财政年份:2009
- 资助金额:
$ 101.03万 - 项目类别:
Research Grant
A cognitive vaccine for depression: assessment using neurobiological outcomes in experimental medicine models
抑郁症认知疫苗:在实验医学模型中使用神经生物学结果进行评估
- 批准号:
G0701672/1 - 财政年份:2008
- 资助金额:
$ 101.03万 - 项目类别:
Research Grant
Can we integrate cognitive-behavioural and pharmacological theories of anxiety?
我们可以整合焦虑的认知行为和药理学理论吗?
- 批准号:
G0501223/1 - 财政年份:2006
- 资助金额:
$ 101.03万 - 项目类别:
Research Grant
相似国自然基金
TXNIP调控实验性青光眼视乳头星形胶质细胞的激活及其机制研究
- 批准号:82371048
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
GLS1通过α-KG调控表观遗传修饰在实验性近视巩膜重塑中的作用机制
- 批准号:82371092
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
多发性硬化相关microRNA和靶基因鉴定及其对Th17和Treg细胞生成及分化的作用
- 批准号:81171120
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues
用于抑制牙齿组织中蛋白水解酶的基于生物响应和免疫蛋白的疗法
- 批准号:
10555093 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别:
Accelerating drug discovery via ML-guided iterative design and optimization
通过机器学习引导的迭代设计和优化加速药物发现
- 批准号:
10552325 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别:
The Gut as a Target to Improve Outcomes in Sepsis
肠道作为改善脓毒症预后的目标
- 批准号:
10552403 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别:
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
- 批准号:
10638364 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别:
Manipulation of Host Tissue to Induce a Hierarchical Microvasculature
操纵宿主组织以诱导分层微脉管系统
- 批准号:
10637683 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别:
Advanced Sample Preparation, Separation and Multiplexed Analysis for In-Depth Proteome Profiling of >1000 Single Cells Per Day
先进的样品制备、分离和多重分析,每天对超过 1000 个单细胞进行深入的蛋白质组分析
- 批准号:
10642310 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别:
Intratumor heterogeneity in BRCA1-mutated breast cancer metastasis
BRCA1 突变乳腺癌转移的瘤内异质性
- 批准号:
10680318 - 财政年份:2023
- 资助金额:
$ 101.03万 - 项目类别: